Trulicity vs Ozempic: approved uses, pens, doses and cost
The short answer
Trulicity vs Ozempic compares two once-weekly injections approved for type 2 diabetes. Trulicity (dulaglutide) is also approved for children 10 and older. Ozempic (semaglutide) adds a kidney use. Self-pay is $349 a month for Ozempic 0.25 mg to 1 mg through NovoCare Pharmacy and starts at $389 a month for Trulicity through LillyDirect.
Key takeaways
- A Trulicity pen holds one dose. An Ozempic pen holds several doses and takes a new needle each time.
- Only Trulicity is approved for children 10 and older. Only the Ozempic injection has a kidney use, in adults with chronic kidney disease.
- Miss a dose and the rules differ: Ozempic counts 5 days from the due date, Trulicity needs 3 days before the next dose.
- Paying cash? Ozempic is $349 a month up to 1 mg through NovoCare. Trulicity starts at $389 through LillyDirect.
- No label matches a Trulicity dose to an Ozempic dose. Your prescriber decides where you start and when.
Ozempic vs Trulicity, side by side
| Ozempic | Trulicity | |
|---|---|---|
| Active ingredient | semaglutide | dulaglutide |
| Maker | Novo Nordisk | Eli Lilly and Company |
| FDA-approved uses |
|
|
| How it is taken | weekly (multi-dose pen); daily (tablet) | weekly (single-dose pen) |
| Strengths | 0.25 to 9 mg | 0.75 to 4.5 mg |
| Label starting dose |
|
|
| Cheapest verified self-pay | No self-pay price listed | $389 per fill at 4.5 mg |
| With covering commercial insurance | No savings-card price listed | No savings-card price listed |
| Medicare GLP-1 Bridge | No | No |
| Label | Revised: 5/2026 (DailyMed version 20) | Revised: 3/2026 (DailyMed version 62) |
| Reaction | Ozempic 1 mg | Placebo |
|---|---|---|
| Nausea | 20.3% | 6.1% |
| Vomiting | 9.2% | 2.3% |
| Diarrhea | 8.8% | 1.9% |
| Abdominal pain | 5.7% | 4.6% |
| Constipation | 3.1% | 1.5% |
| Reaction | 1.5 mg | Placebo |
|---|---|---|
| Nausea | 21.1% | 5.3% |
| Vomiting | 12.7% | 2.3% |
| Diarrhea | 12.6% | 6.7% |
| Abdominal Pain | 9.4% | 4.9% |
| Decreased Appetite | 8.6% | 1.6% |
| Dyspepsia | 5.8% | 2.3% |
Each table comes from that medicine's own trials. The trials differ in who was studied and for how long, so the percentages are not a head-to-head comparison.
Trulicity and Ozempic have a lot in common on paper: one injection a week, type 2 diabetes, a cardiovascular use on each label. They’re still different medicines, and the practical differences are the kind you notice every week: how the pen works, what happens when you miss a dose, how long a pen can sit out of the fridge, and what the cash price is. This page works through them using the FDA labels (Revised: 5/2026 (DailyMed version 20) for Ozempic injection, Revised: 3/2026 (DailyMed version 62) for Trulicity) and our price records.
Trulicity or Ozempic: which suits whom?
- You want one pen, one dose and no needle to attach. That’s Trulicity’s design.
- The patient is a child aged 10 or older with type 2 diabetes. Trulicity is the one of the two approved for that.
- You have type 2 diabetes and chronic kidney disease. That use appears on the Ozempic injection label and not on Trulicity’s. Ozempic is for adults.
- You’re paying cash. Ozempic is $349 a month at 0.25 mg, 0.5 mg and 1 mg, and Trulicity starts at $389 a month at every strength. At Ozempic’s top dose, the price rises to $499.
- You have commercial coverage. Ozempic has a savings offer (as little as $25).
- You’re on Medicare. Both are Part D diabetes medicines. Neither is in the Medicare GLP-1 Bridge.
Nothing on this page ranks one above the other for blood sugar or weight. Before you decide with your prescriber, ask your plan which one it prefers, and ask a pharmacist to show you both pens.
What is each approved for?
Trulicity (dulaglutide, Eli Lilly) has two uses: improving blood sugar control in adults and children 10 years and older with type 2 diabetes, and reducing major cardiovascular events (serious heart and blood vessel events) in adults with type 2 diabetes who have established cardiovascular disease or multiple cardiovascular risk factors. Its safety and effectiveness have not been established in children under 10.
Ozempic injection (semaglutide, Novo Nordisk) has three, all in adults with type 2 diabetes: improving blood sugar control, reducing major cardiovascular events in those with established cardiovascular disease, and reducing the risk of sustained eGFR decline (a lasting drop in a measure of kidney function), end-stage kidney disease and cardiovascular death in those with chronic kidney disease.
Two differences stand out. Trulicity’s cardiovascular use reaches adults with multiple risk factors as well as those with established disease. Ozempic has the kidney use. Neither label includes weight management.
Ozempic also comes as a daily tablet on a separate label. That form is covered in Ozempic vs Rybelsus. The rest of this page is about the pens.
How do the pens differ?
This is the most visible difference between the two.
Trulicity comes only as a single-dose pen. Each pen holds one weekly dose and is thrown away after use. A carton holds four pens, a 28-day supply. You pick up the strength you were prescribed, and there’s no dose to select on the pen.
Ozempic is a multi-dose pen for one person. At a steady dose, one pen delivers four weekly injections. NovoFine Plus needles come with it, and the label says to use a new needle for each injection and to store the pen with no needle attached. The pen must never be shared, even with a new needle.
Storage follows from the design. An Ozempic pen in use can be kept for 56 days at room temperature or in a refrigerator. Then it’s thrown away, even if medicine remains. A Trulicity pen lives in the refrigerator, and if needed can be kept at room temperature, not above 86°F (30°C), for a total of 14 days.
How do the doses step up?
Trulicity: 0.75 mg, 1.5 mg, 3 mg, 4.5 mg. The label starts at 0.75 mg once weekly. After 4 weeks, the dose may be increased to 1.5 mg for more blood sugar control, and then in 1.5 mg steps, each after at least 4 weeks. The maximum recommended adult dose is 4.5 mg. For children, it’s 1.5 mg.
Ozempic: 0.25 mg, 0.5 mg, 1 mg, 2 mg. The label starts at 0.25 mg once weekly for 4 weeks, a starting step, then 0.5 mg. If more control is needed after at least 4 weeks, the dose may go to 1 mg, and later to 2 mg, the maximum.
Trulicity’s starting dose is one a person can stay on. Ozempic’s 0.25 mg is a 4-week starting step. The milligrams aren’t comparable between the two drugs. The titration schedule tool lays each path out on a calendar.
Missed doses work in opposite directions
Both are taken on the same day each week, at any time of day, with or without food. If you miss a dose, the labels ask different questions.
- Ozempic looks back. Take the missed dose as soon as possible within 5 days after it was due. If more than 5 days have passed, skip it.
- Trulicity looks ahead. Take the missed dose if there are at least 3 days (72 hours) until the next scheduled dose. If fewer remain, skip it.
The missed dose tool applies the right rule for each.
What does each cost?
Here are the prices on each route:
Ozempic pen
- NovoCare Pharmacy self-pay: $349 a month for 0.25 mg, 0.5 mg or 1 mg, and $499 a month for 2 mg.
- New self-pay patients: $199 for each of the first two monthly fills of 0.25 mg or 0.5 mg through December 31, 2026, then $349.
- Savings offer with commercial insurance that covers it: as little as $25.
- List price (the full price before any discount): $1,027.51 per pen.
Trulicity pen
- LillyDirect self-pay: starting at $389 a month, the same starting price shown for every strength.
- List price: $1,006.93 per month (four pens).
Over a year, the shape of the two price lists matters. Trulicity’s cash price doesn’t change with the dose, so a year at any strength is $5,057 at the LillyDirect starting price. Ozempic’s steps up at the top dose: a year at 1 mg is $4,537 and a year at 2 mg is $6,487.
The Ozempic cost page and the Trulicity cost guide cover every route, and the cost calculator will price either for a year.
Does insurance or Medicare cover them?
Both are diabetes medicines, and many commercial plans list one or both, sometimes with one as the preferred option and the other needing prior authorization (the plan’s approval before it pays) or a trial of the preferred drug first. Ask your plan which is preferred on your formulary (its list of covered drugs). That answer often decides the choice before price does.
For Medicare, CMS states that type 2 diabetes is an indication eligible for Part D coverage, so both go through your Part D plan. Neither drug is part of the Medicare GLP-1 Bridge, and a type 2 diabetes diagnosis rules a person out of the Bridge in any case.
One scheduled change applies to Ozempic. Under the Medicare Drug Price Negotiation Program, the negotiated price for a 30-day supply of semaglutide is $274 from January 1, 2027. Your copay will still depend on your plan. The Medicare guide explains more.
How do the side effects compare?
Both labels report mostly gastrointestinal (stomach and bowel) reactions. The trials were separate, with different patients and durations, so the two sets of figures shouldn’t be read against each other.
Trulicity. In the label’s pool of placebo-controlled trials, nausea was reported by 12.4 percent of people on 0.75 mg and 21.1 percent on 1.5 mg, compared with 5.3 percent on placebo. In a separate 36-week trial of the higher doses, with no placebo group, nausea was reported by 13.4 percent on 1.5 mg, 15.6 percent on 3 mg and 16.4 percent on 4.5 mg.
Ozempic. In the label’s placebo-controlled trials, nausea was reported by 15.8 percent of patients on 0.5 mg and 20.3 percent on 1 mg, compared with 6.1 percent on placebo.
Both carry a boxed warning about thyroid C-cell tumors. Neither should be used by people with a personal or family history of medullary thyroid carcinoma (a type of thyroid cancer) or with MEN 2 (an inherited condition linked to it). Both labels warn about low blood sugar when used with insulin or a sulfonylurea (a type of diabetes medicine), and about diabetic retinopathy complications (eye problems from diabetes).
Can you switch between Trulicity and Ozempic?
Neither label gives instructions for switching from another GLP-1 medicine. Each states only its own starting dose: 0.25 mg once weekly for Ozempic, 0.75 mg once weekly for Trulicity. No label table matches a Trulicity dose to an Ozempic dose, and we don’t publish a conversion.
That leaves the decision with your prescriber, who’ll choose the starting dose and the timing of your first injection of the new medicine. Our switching guides and the switching planner show what each label does say. For more pairings, including Mounjaro vs Trulicity, see the comparison hub.
Frequently asked questions
What is the difference between Trulicity and Ozempic?
They're different medicines for type 2 diabetes, each injected once a week. Trulicity is dulaglutide from Eli Lilly, in a single-dose pen, approved for adults and children 10 and older. Ozempic is semaglutide from Novo Nordisk, in a multi-dose pen, approved for adults, with an extra use in chronic kidney disease. Their doses, missed-dose rules and prices all differ.
Is Trulicity or Ozempic cheaper?
Ozempic self-pay through NovoCare Pharmacy is $349 a month for 0.25 mg, 0.5 mg or 1 mg and $499 for 2 mg. Trulicity self-pay through LillyDirect starts at $389 a month at every strength. With insurance, your plan's formulary and copay decide, and plans differ.
Can I switch from Trulicity to Ozempic?
Neither label gives switching instructions. The Ozempic injection label only states its starting dose, 0.25 mg once weekly, and the Trulicity label only states its own, 0.75 mg once weekly. No label converts a Trulicity dose to an Ozempic dose. Your prescriber decides where you start and when.
Which pen is easier to use, Trulicity or Ozempic?
They work differently. A Trulicity pen holds one dose and is thrown away after the injection, and a carton has four. An Ozempic pen holds several doses, takes a new needle for each injection, and is kept for up to 56 days once in use. Which you find easier is personal, and a pharmacist can show you both.
Does Medicare cover Trulicity and Ozempic?
Type 2 diabetes is an indication eligible for Part D coverage, so both run through your Part D plan's formulary and your cost depends on the plan. Neither is part of the Medicare GLP-1 Bridge. From January 1, 2027, the negotiated Medicare price for semaglutide, which includes Ozempic, is $274 for a 30-day supply.
Sources (22)
- 1.FDA label (DailyMed): Ozempic prescribing information, section 2.1
“Administer OZEMPIC once weekly, on the same day each week, at any time of the day, with or without meals.”
- 2.FDA label (DailyMed): Ozempic prescribing information, section 3
“Injection: 2 mg/3 mL (0.68 mg/mL) for 4 doses of 0.25 mg and 2 doses of 0.5 mg or 4 doses of 0.5 mg, 4 mg/3 mL (1.34 mg/mL) for 4 doses of 1 mg, and 8 mg/3 mL (2.68 mg/mL) for 4 doses of 2 mg in single-patient-use pens”
- 3.FDA label (DailyMed): Ozempic prescribing information, section 16
“Always remove and safely discard the needle after each injection and store the OZEMPIC pen without an injection needle attached. Always use a new needle for each injection.”
- 4.FDA label (DailyMed): Ozempic prescribing information, Instructions for Use
“NovoFine® Plus 32G 4 mm disposable needles are included with your OZEMPIC pen.”
- 5.FDA label (DailyMed): Ozempic prescribing information, section 16
“Each OZEMPIC multi-dose pen is for use by a single patient. An OZEMPIC pen must never be shared between patients, even if the needle is changed”
- 6.FDA label (DailyMed): Ozempic prescribing information, section 16
“After first use of the OZEMPIC pen, the pen can be stored for 56 days at controlled room temperature 15°C to 30°C (59°F to 86°F) or in a refrigerator 2°C to 8°C (36°F to 46°F). Do not freeze. Keep the pen cap on when not in use. OZEMPIC should be protected from excessive heat and sunlight.”
- 7.FDA label (DailyMed): Ozempic prescribing information, Instructions for Use
“The OZEMPIC pen you are using should be disposed of (thrown away) after 56 days, even if it still has OZEMPIC left in it.”
- 8.FDA label (DailyMed): Ozempic prescribing information, section 4
“A personal or family history of MTC or in patients with MEN 2”
- 9.FDA label (DailyMed): Trulicity prescribing information, section 2.4
“Administer TRULICITY once weekly, any time of day, with or without food.”
- 10.FDA label (DailyMed): Trulicity Medication Guide (in the prescribing information)
“Use TRULICITY 1 time each week on the same day each week at any time of the day.”
- 11.FDA label (DailyMed): Trulicity prescribing information, section 2.1
“The maximum recommended dosage is 4.5 mg injected subcutaneously once weekly.”
- 12.FDA label (DailyMed): Trulicity prescribing information, section 16.2
“If needed, each single-dose pen can be kept at room temperature, not to exceed 86°F (30°C) for a total of 14 days.”
- 13.FDA label (DailyMed): Trulicity prescribing information, section 8.4
“The safety and effectiveness of TRULICITY have not been established in pediatric patients less than 10 years of age.”
- 14.FDA label (DailyMed): Trulicity prescribing information, section 4
“TRULICITY is contraindicated in patients with: Personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) [see Warnings and Precautions (5.1)].”
- 15.CMS: Information for Part D Plans
“Type 2 diabetes, moderate to severe obstructive sleep apnea, and noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver scarring (fibrosis) indications are eligible for Part D coverage. [...] If a Medicare Part D beneficiary has a prescription for a GLP-1 drug for an indication covered under Medicare Part D, they should continue to obtain their GLP-1 through their Part D plan.”
- 16.CMS: Medicare Drug Price Negotiation Program: Negotiated Prices for Initial Price Applicability Year 2027
“Below is the list of negotiated prices, which the statute refers to as maximum fair prices (MFPs), for the 15 selected drugs covered under Medicare Part D that will go into effect beginning January 1, 2027, based on negotiations and agreements reached between CMS and participating drug companies. [table] Drug Name: Ozempic; Rybelsus; Wegovy. Participating Drug Company: Novo Nordisk Inc. Agreed to Negotiated Price for 30-day Supply for CY 2027: $274. List Price for 30-day Supply, CY 2024: $959. Discount of Negotiated Price from 2024 List Price: 71%.”
- 17.
- 18.
- 19.
- 20.
- 21.
- 22.
Related pages
- What is Ozempic? Uses, doses, cost and how to take it
- What is Trulicity (dulaglutide)? Uses, doses, cost and side effects
- Mounjaro vs Trulicity: uses, doses, cost and the one head-to-head trial
- Rybelsus vs Ozempic: tablet or pen, doses, cost and switching
- Cost calculator
- Wegovy vs Ozempic: what is the difference?
